ConductScience.org, home

Paper23908736

AIDS and drug rationing.

Sharif PS and 1 other. J Med Ethics Hist Med, 2010. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. AIDS and drug rationing. Papers, record 23908736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908736

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AIDS and drug rationing.
PubMed
Journal
J Med Ethics Hist Med
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2021-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharif PSPooneh Salari
2Noroozi MMahshad

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116652038Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.J Acquir Immune Defic Syndr2006https://conductscience.org/library/papers/16652038PubMed
218832873Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.AIDS2008https://conductscience.org/library/papers/18832873PubMed
39357338Ethical challenges posed by clinical progress in AIDS.Am J Public Health1997https://conductscience.org/library/papers/9357338PubMed
417243067Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.Clin Infect Dis2007https://conductscience.org/library/papers/17243067PubMed
516563042Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility.PLoS Med2006https://conductscience.org/library/papers/16563042PubMed
611873003HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?AIDS2002https://conductscience.org/library/papers/11873003PubMed
715097305Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.J Acquir Immune Defic Syndr2004https://conductscience.org/library/papers/15097305PubMed
816159308Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.PLoS Med2005https://conductscience.org/library/papers/16159308PubMed
917227932Survival of persons with and without HIV infection in Denmark, 1995-2005.Ann Intern Med2007https://conductscience.org/library/papers/17227932PubMed
1016530575Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.Lancet2006https://conductscience.org/library/papers/16530575PubMed
1116741877The survival benefits of AIDS treatment in the United States.J Infect Dis2006https://conductscience.org/library/papers/16741877PubMed
1216430196Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.Antivir Ther2005https://conductscience.org/library/papers/16430196PubMed
1314760894Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.Antivir Ther2003https://conductscience.org/library/papers/14760894PubMed
1416355337Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.Clin Infect Dis2006https://conductscience.org/library/papers/16355337PubMed
1515883177Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability.J Antimicrob Chemother2005https://conductscience.org/library/papers/15883177PubMed
1616860698
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.
Lancet2006https://conductscience.org/library/papers/16860698PubMed
1719020325Early antiretroviral therapy and mortality among HIV-infected infants.N Engl J Med2008https://conductscience.org/library/papers/19020325PubMed
1817457091HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.AIDS2007https://conductscience.org/library/papers/17457091PubMed
1916691068Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.AIDS2006https://conductscience.org/library/papers/16691068PubMed
2011172188Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.N Engl J Med2001https://conductscience.org/library/papers/11172188PubMed

See all 37 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23908736

GET https://conductscience.org/api/papers/v1/23908736/references?page=2